Literature DB >> 21354459

Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study.

Allison R Baker1, Sarah Zalwango, LaShaunda L Malone, Robert P Igo, Feiyou Qiu, Mary Nsereko, Mark D Adams, Pamela Supelak, Harriet Mayanja-Kizza, W Henry Boom, Catherine M Stein.   

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), causes 9 million new cases worldwide and 2 million deaths annually. Genetic linkage and association analyses have suggested several chromosomal regions and candidate genes involved in TB susceptibility. This study examines the association of TB disease susceptibility with a selection of biologically relevant genes on regions on chromosomes 7 (IL6 and CARD11) and 20 (CTSZ and MC3R) and fine mapping of the chromosome 7p22-p21 region identified through our genome scan. We analyzed 565 individuals from Kampala, Uganda, who were previously included in our genome-wide linkage scan. Association analyses were conducted for 1,417 single-nucleotide polymorphisms (SNP) that passed quality control. None of the candidate gene or fine mapping SNPs was significantly associated with TB susceptibility (p > 0.10). When we restricted the analysis to HIV-negative individuals, 2 SNPs on chromosome 7 were significantly associated with TB susceptibility (p < 0.05). Haplotype analyses identified a significant risk haplotype in cathepsin X (CTSZ; p = 0.0281, odds ratio = 1.5493, 95% confidence interval [1.039, 2.320]).
Copyright © 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21354459      PMCID: PMC3078986          DOI: 10.1016/j.humimm.2011.02.016

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  45 in total

Review 1.  Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

Review 2.  Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

3.  Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family.

Authors:  C M Greenwood; T M Fujiwara; L J Boothroyd; M A Miller; D Frappier; E A Fanning; E Schurr; K Morgan
Journal:  Am J Hum Genet       Date:  2000-07-05       Impact factor: 11.025

4.  Genetic susceptibility to tuberculosis in Africans: a genome-wide scan.

Authors:  R Bellamy; N Beyers; K P McAdam; C Ruwende; R Gie; P Samaai; D Bester; M Meyer; T Corrah; M Collin; D R Camidge; D Wilkinson; E Hoal-Van Helden; H C Whittle; W Amos; P van Helden; A V Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  Polymorphisms in MC3R promoter and CTSZ 3'UTR are associated with tuberculosis susceptibility.

Authors:  Lindsey A Adams; Marlo Möller; Almut Nebel; Stefan Schreiber; Lize van der Merwe; Paul D van Helden; Eileen G Hoal
Journal:  Eur J Hum Genet       Date:  2011-02-02       Impact factor: 4.246

6.  Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis.

Authors:  I Kramnik; W F Dietrich; P Demant; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 7.  Innate immunity to Mycobacterium tuberculosis.

Authors:  Reinout van Crevel; Tom H M Ottenhoff; Jos W M van der Meer
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

Review 8.  Patterns of linkage disequilibrium in the human genome.

Authors:  Kristin G Ardlie; Leonid Kruglyak; Mark Seielstad
Journal:  Nat Rev Genet       Date:  2002-04       Impact factor: 53.242

Review 9.  Genetic epidemiology of tuberculosis susceptibility: impact of study design.

Authors:  Catherine M Stein
Journal:  PLoS Pathog       Date:  2011-01-20       Impact factor: 6.823

10.  Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.

Authors:  Thorsten Thye; Fredrik O Vannberg; Rolf D Horstmann; Adrian V S Hill; Sunny H Wong; Ellis Owusu-Dabo; Ivy Osei; John Gyapong; Giorgio Sirugo; Fatou Sisay-Joof; Anthony Enimil; Margaret A Chinbuah; Sian Floyd; David K Warndorff; Lifted Sichali; Simon Malema; Amelia C Crampin; Bagrey Ngwira; Yik Y Teo; Kerrin Small; Kirk Rockett; Dominic Kwiatkowski; Paul E Fine; Philip C Hill; Melanie Newport; Christian Lienhardt; Richard A Adegbola; Tumani Corrah; Andreas Ziegler; Andrew P Morris; Christian G Meyer
Journal:  Nat Genet       Date:  2010-08-08       Impact factor: 38.330

View more
  9 in total

1.  Association analysis of melanocortin 3 receptor polymorphisms with the risk of pulmonary tuberculosis.

Authors:  Byung Lae Park; Lyoung Hyo Kim; Suhg Namgoong; Ji On Kim; Jason Yongha Kim; Hun Soo Chang; Jong Sook Park; An Soo Jang; Sung Woo Park; Do Jin Kim; Ki Up Kim; Yang Gee Kim; Soo-Taek Uh; Ki Hyun Seo; Young Hoon Kim; Choon Sik Park; Hyoung Doo Shin
Journal:  Lung       Date:  2014-07-27       Impact factor: 2.584

Review 2.  Innate immune gene polymorphisms in tuberculosis.

Authors:  Abul K Azad; Wolfgang Sadee; Larry S Schlesinger
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

3.  Spontaneous latency in a rabbit model of pulmonary tuberculosis.

Authors:  Selvakumar Subbian; Liana Tsenova; Paul O'Brien; Guibin Yang; Nicole L Kushner; Sven Parsons; Blas Peixoto; Dorothy Fallows; Gilla Kaplan
Journal:  Am J Pathol       Date:  2012-09-05       Impact factor: 4.307

4.  NELFCD and CTSZ loci are associated with jaundice-stage progression in primary biliary cholangitis in the Japanese population.

Authors:  Nao Nishida; Yoshihiro Aiba; Yuki Hitomi; Minae Kawashima; Kaname Kojima; Yosuke Kawai; Kazuko Ueno; Hitomi Nakamura; Noriyo Yamashiki; Tomohiro Tanaka; Sumito Tamura; Akira Mori; Shintaro Yagi; Yuji Soejima; Tomoharu Yoshizumi; Mitsuhisa Takatsuki; Atsushi Tanaka; Kenichi Harada; Shinji Shimoda; Atsumasa Komori; Susumu Eguchi; Yoshihiko Maehara; Shinji Uemoto; Norihiro Kokudo; Masao Nagasaki; Katsushi Tokunaga; Minoru Nakamura
Journal:  Sci Rep       Date:  2018-05-23       Impact factor: 4.379

5.  MAV_4644 Interaction with the Host Cathepsin Z Protects Mycobacterium avium subsp. hominissuis from Rapid Macrophage Killing.

Authors:  Matthew S Lewis; Lia Danelishvili; Sasha J Rose; Luiz E Bermudez
Journal:  Microorganisms       Date:  2019-05-21

6.  Cathepsin X in serum from patients with colorectal cancer: relation to prognosis.

Authors:  Tjasa Vizin; Ib Jarle Christensen; Hans Jørgen Nielsen; Janko Kos
Journal:  Radiol Oncol       Date:  2012-07-24       Impact factor: 2.991

7.  The household contact study design for genetic epidemiological studies of infectious diseases.

Authors:  Catherine M Stein; Noémi B Hall; Lashaunda L Malone; Ezekiel Mupere
Journal:  Front Genet       Date:  2013-04-30       Impact factor: 4.599

8.  Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients.

Authors:  Tjaša Vižin; Ib Jarle Christensen; Michael Wilhelmsen; Hans Jørgen Nielsen; Janko Kos
Journal:  BMC Cancer       Date:  2014-04-13       Impact factor: 4.430

9.  [Clinical significance of detection of cathepsin X and cystatin C in the sera of patients with lung cancer].

Authors:  Xuede Zhang; Yanli Hou; Zequn Niu; Wei Li; Xia Meng; Na Zhang; Shuanying Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-08-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.